Nationwide
A Study to Investigate the Efficacy, Safety, Tolerability and Pharmacokinetics of PKN605 in Participants With Atrial Fibrillation
Novartis Pharmaceuticals
Ph 2·~2yr·5 sites in MS, NC, NY +2
Enrolling now
Check if I qualifyShowing 1–24 of 46 trials
Novartis Pharmaceuticals
Yale University
Icahn School of Medicine at Mount Sinai
Massachusetts General Hospital
University of Chicago
University of Rochester
Regeneron Pharmaceuticals
Hamilton Health Sciences Corporation
Johns Hopkins University
University of Utah
Biosense Webster, Inc.
Population Health Research Institute
University of California, San Francisco
University of California, San Francisco
Kansas City Heart Rhythm Research Foundation
University of California, San Francisco
McMaster University
Malini Madhavan